Navigation Links
Alfacell Provides Shareholder Update
Date:6/19/2009

emotherapy out of the cells, so anything that will interfere with this function may allow more drug to come into the cells and cause death of the cancer. Another major master controller gene known as nfkB is also known to be elevated when normal cells turn into mesothelioma cells, and high levels of this gene have been associated with resistance to chemotherapy. In order to investigate whether Onconase specifically targets these three genes, we added Onconase to three mesothelioma cell lines at a dose which is achievable in humans, and then using molecular biology techniques including polymerase chain reaction, measured the levels of the MDR and nfkB genes after treatment with the drug. Striking decreases in all of these genes in the mesothelioma cell lines were seen after treatment with Onconase validating the hypothesis that one of the mechanisms of action of Onconase is to decrease resistance to chemotherapy. Moreover, these data in cell lines are complemented by most recent animal study in mice bearing tumors of varying sensitivity to Cisplatin and Carbo Platinum. In all of the animal models, the addition of Onconase to Cisplatin significantly increased the tumor growth inhibition compared to Cisplatin or Onconase alone, and in the tumor model most resistant to platinum, Onconase addition to platinum increased tumor growth inhibition from 37% to 73%. These in vitro and in vivo data, which are presently being prepared for publication emphasize the uniqueness of Onconase in its ability to directly modulate chemotherapy sensitivity, and mandate a trial in non-small cell lung cancer to prospectively demonstrate increased tumor responses when Onconase is added to a standard lung cancer chemotherapy regimen." Another independent study in vivo is underway that may confirm Dr. Pass' in vitro study.

After much thought, consideration, and input from highly respected lung experts, we have decided our path moving forward would be t
'/>"/>

SOURCE Alfacell Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Alfacell Provides ONCONASE(R) NDA Submission Update
2. Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacells ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
3. Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel
4. Alfacell Corporation Announces Preliminary Results From ONCONASE(R) Phase IIIb Clinical Trial
5. Alfacells ONCONASE(R) Shows Potential as Radiation Sensitizer for Lung Cancer Treatment
6. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
7. Alfacell Reports Financial Results for First Quarter of Fiscal 2008
8. Alfacell Corporation to Present at UBS Global Life Sciences Conference
9. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
10. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
11. Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)...  Pomerantz LLP is investigating claims on behalf of ... (NASDAQ: VTAE ).  Such investors are advised ... rswilloughby@pomlaw.com or 888-476-6529, ext. 237. The ... and/or directors have violated Sections 10(b) and 20(a) of ... On February 27, 2015, the Company announced that its ...
(Date:2/27/2015)... -- Following a bipartisan vote in the House Ways ... Medicare DMEPOS Competitive Bidding Improvement Act of 2015 ... a statement praising the Committee,s work and pushing ... "Today,s mark-up of the Competitive Bidding Improvement ... is a critical step forward for this bipartisan, ...
(Date:2/27/2015)... 27, 2015 Isis Pharmaceuticals, Inc. (Nasdaq: ... its pro forma net operating loss (NOL) guidance and ... financial position.  Isis, significantly improved financial results were due ... in payments the Company received from its partners.  Isis, ... a nearly 60% improvement over its 2013 NOL of ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vitae Pharmaceuticals, Inc. - VTAE 2Bidding Fix Takes Major Step Forward After Bipartisan Vote of House Ways and Means Committee 2Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17
... Mass. , July 1 Shire plc (LSE: ... today announced positive data from its long-term extension to its ... alfa), the company,s enzyme replacement therapy for patients with type ... Annual European Working Group on Gaucher Disease (EWGGD) in ...
... Prasco Laboratories announced today that it ... (omeprazole/sodium bicarbonate) capsules. Authorized generics are generic pharmaceuticals manufactured ... private label. Under the terms of a distribution and ... the capsule form of Omeprazole/Sodium Bicarbonate in 20 mg ...
Cached Medicine Technology:Data Presented at the European Working Group on Gaucher Disease Demonstrate Continuous Improvements in Bone Mineral Density for VPRIV(R) (Velaglucerase Alfa) Through 69 Months 2Data Presented at the European Working Group on Gaucher Disease Demonstrate Continuous Improvements in Bone Mineral Density for VPRIV(R) (Velaglucerase Alfa) Through 69 Months 3Data Presented at the European Working Group on Gaucher Disease Demonstrate Continuous Improvements in Bone Mineral Density for VPRIV(R) (Velaglucerase Alfa) Through 69 Months 4Data Presented at the European Working Group on Gaucher Disease Demonstrate Continuous Improvements in Bone Mineral Density for VPRIV(R) (Velaglucerase Alfa) Through 69 Months 5Data Presented at the European Working Group on Gaucher Disease Demonstrate Continuous Improvements in Bone Mineral Density for VPRIV(R) (Velaglucerase Alfa) Through 69 Months 6Prasco to Market Authorized Generic of ZEGERID® 2
(Date:2/28/2015)... Chicago, IL (PRWEB) February 28, 2015 ... growth, Chunk Fitness has added an additional exercise to ... as the oblique exercise is most commonly known as, ... equipment. , “Rope Pulls” are executed in a relatively ... varying fitness and strength levels. The full description of ...
(Date:2/28/2015)... The Classic Denture Center , ... special. Throughout all of March patients can receive ... service can help overall mouth health and ... may notice certain symptoms that suggest the denture teeth ... include: , 1.    Pain, clicking, and popping in the joints, ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 Mew and ... announced that they now provide business consulting services in ... as corporate tax planning and succession planning. Company finances ... to experienced professionals. On top of this, complex Canadian ... handle corporate accounting. As a result, Mew and Company ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 Indosoft ... software suite for Asterisk, are pleased to announce the ... successful 5.7 and 5.8 versions of Q-Suite, this new ... as a number of new features to the leading ... 2015. , Q-Suite 5.9 will add features to enhance ...
(Date:2/28/2015)... February 28, 2015 For those people ... person, the Mesothelioma Applied Research Foundation (Meso ... Tuesday, March 3, starting at 9:30 AM. , The ... registration. The broadcast can be accessed through any browser ... . , The Symposium is a unique event that ...
Breaking Medicine News(10 mins):Health News:Classic Denture Center in Portland Oregon is Offering March Discount 2Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2Health News:Indosoft Proudly Announces Q-Suite 5.9 Call Center Software for Asterisk 2Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2
... 65 year old retired heart surgeon place first in an Ironman Competition? ... less than 13 hours which qualified him for the Kona, Hawaii Ironman. ... ... surgeon Dwight Lundell gave himself the perfect 65th birthday gift. He placed ...
... the iPhone version of its acclaimed mobile charge capture ... makes it easy for physicians to track their patients, ... quickly. ,pMDsoft,s native application is the first charge ... the App Store, so it can be used even ...
... More than half a million babies are born preterm in ... the rise. Late preterm births, or births that occur ... before the mother,s due date), account for more than 70% ... babies, many people are unaware of the serious health problems ...
... , ATLANTIC CITY, N.J., Dec. 10 A letter ... Iraq conflict and recuperating at Walter Reed Army Hospital in Washington, DC ... Atlantic City. , , The letter, detailing ... war injuries and wishing for the chance to take a break from ...
... Mich., Dec. 10 News stories this,afternoon by ... information about Executive Order (EO) budget cuts proposed ... reported:,"Another $5.3 million will be saved by cutting ... the EO cuts do not reduce provider,payments for ...
... holds up, it might lead to cures, researchers say ... identified common genetic mutations between type 1 diabetes and ... stem from a shared underlying mechanism. , The ... triggered by similar environmental factors. , "Our results ...
Cached Medicine News:Health News:Retired Heart Surgeon Dr. Dwight Lundell Celebrates 65th Birthday by Placing First in Arizona Ironman Competition 2Health News:pMDsoft Releases Native Charge Capture Software for iPhone 2Health News:pMDsoft Releases Native Charge Capture Software for iPhone 3Health News:pMDsoft Releases Native Charge Capture Software for iPhone 4Health News:pMDsoft Releases Native Charge Capture Software for iPhone 5Health News:Late preterm births present serious risks to newborns 2Health News:Wounded Warriors to be Holiday Guests of Harrah's Entertainment 2Health News:Genetic Link Between Type 1 Diabetes, Celiac Disease Seen 2Health News:Genetic Link Between Type 1 Diabetes, Celiac Disease Seen 3
Angulated, blunt tips....
Split adult return electrode grounding pad with 2.8 m cable, 50/box....
15" Monopolar Electrode, Ins., Hook Tip...
... implements the confocal principle, the design of ... It allows multi fluorescence images to be ... flexibility for individual applications. Entirely new acquisition ... efficient structural and functional analysis of your ...
Medicine Products: